HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Cancer Genome Projects: Updates on major cancer genome sequencing efforts.

Cancer Genome Projects: Updates on major cancer genome sequencing efforts.

Cancer genome sequencing projects represent a significant leap in understanding the genetic foundations of cancer. By analyzing the DNA of various cancer types, these efforts have identified mutations that drive tumor development and progression. Large-scale initiatives like The Cancer Genome Atlas (TCGA) and the International Cancer Genome Consortium (ICGC) have mapped numerous cancer genomes, offering invaluable insights into oncogenes, tumor suppressor genes, and the complex interplay of genetic pathways. These findings have led to the development of targeted therapies, improving treatment outcomes. Moreover, integrating genomic data with clinical information allows for the classification of tumors into molecular subtypes, enabling personalized treatment plans. As technology advances, researchers are delving deeper into non-coding regions of the genome and rare mutations, uncovering previously hidden aspects of cancer biology. These discoveries are pivotal in designing innovative diagnostic tools, refining therapeutic approaches, and ultimately improving patient survival rates.

Committee Members
Committee Member - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Committee Member - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp